Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
HOWL
#3650
Werewolf Therapeutics, Inc. Common Stock
0.6
0
-1.64%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.64%
Monatliche Änderung
-11.76%
6 month change
-55.88%
Jahresänderung
-49.15%
Vorheriger Schlusskurs
0.6
1
Open
0.6
0
Bid
Ask
Low
0.6
0
High
0.6
0
Volumen
3
Märkte
Aktien
Gesundheitswesen
HOWL
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.65 M
35.28 M
42.74 M
44.83 M
—
Valuation ratios
Enterprise value
171.82 M
-56.99 M
63.96 M
-44.65 M
-90.9 M
Price to earnings ratio
-1.09
-1.1
-4.42
-0.91
-3.42
Price to sales ratio
—
73.96
105.89
163.1
—
Price to cash flow ratio
5.13
1.46
5.07
1.16
4.06
Price to book ratio
1.44
0.48
1.49
0.88
1.64
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.28
-0.34
-0.21
-0.56
-0.73
Return on equity %
-0.33
-0.44
-0.34
-0.96
-1.58
Return on invested capital %
-1 040.55
-935.92
-436.07
-964.14
—
Gross margin %
—
100
100
100
—
Operating margin %
—
-7 007
-2 593.02
-18.49 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-6 726.25
-2 392.32
-17.72 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
13.56
5.84
7.14
7.45
24.72
Inventory turnover
—
—
—
—
—
Asset turnover
—
0
0.01
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.19
0.21
0.99
Long term debt to total equity ratio
—
—
0.29
0.36
2.15
Per share metrics
Operating cash flow per share
-2.32
-1.41
-0.91
-1.28
-1.42
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
8.53
4.48
3.77
2.53
7.76
Net current asset value per share
8.73
4.86
3.88
2.58
7.98
Tangible book value per share
8.28
4.24
3.12
1.67
4.53
Working capital per share
8.08
4.03
3.34
2.23
6.65
Book value per share
8.28
4.24
3.12
1.67
4.53
Nachrichten
Biotech-Unternehmen Werewolf Therapeutics prüft Verkauf und strategische Optionen
Werewolf Therapeutics explores sale and strategic alternatives
Werewolf Therapeutics streicht 64 % der Stellen – Aktie gibt nach
Werewolf Therapeutics stock falls after announcing 64% workforce reduction
Werewolf Therapeutics erhält NASDAQ-Rüge wegen Unterschreitung des Mindestkurses/n
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock
Insider-Verkauf bei Werewolf Therapeutics: Director Evnin veräußert Aktien für rund 62.000 $
Werewolf Therapeutics: Director Evnin Luke veräußert Aktien im Wert von 53.533 $/n
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882
H.C. Wainwright senkt Kursziel für Werewolf Therapeutics nach Pipeline-Update drastisch